On the recordOctober 19, 2011
on behalf of Senator DeMint, I ask unanimous consent to set aside the pending amendment and offer amendments Nos. 763 and 764 en bloc. The PRESIDING OFFICER. Without objection, it is so ordered. The clerk will report. The legislative clerk read as follows: The Senator from Missouri [Mr. Blunt], for Mr. DeMint, offers amendments numbered 763 and 764, en bloc. The amendments are as follows: amendment no. 763 (Purpose: To prohibit the use of funds to implement regulations regarding the removal of essential-use designation for epinephrine used in oral pressurized metered-dose inhalers) At the appropriate place, insert the following: Sec. __. None of the funds made available by this Act may be used to implement the final rule entitled ``Use of Ozone- Depleting Substances; Removal of Essential-Use Designation (Epinephrine)'' (73 Fed. Reg. 69532 (November 19, 2008)). amendment no. 764 (Purpose: To eliminate a certain increase in funding) At the appropriate place, insert the following: Sec. 7__. Section 101(a)(2) of division A of the American Recovery and Reinvestment Act of 2009 (Public Law 111-5; 123 Stat. 120; 124 Stat. 2394; 124 Stat. 3265) is amended by striking ``after October 31, 2013'' and inserting ``on the date of enactment of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012''.
